World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

The protective properties of synthetic porphyrin tin complexes in toxic hyperbilirubinemia

    Tin complexes of meso-substituted synthetic porphyrins, namely Sn4+-meso-tetraphenyl- porphyrin (Sn-TPP) and Sn4+-meso-tetrakis(N-methyl-3-pyridyl)porphyrin tetratosylate (Sn-TMe-3-PyP), efficiently decrease the serum bilirubin level when injected subcutaneously at a dose of 100 μM kg−1 body weight into mice. These compounds are active during hyperbilirubinemia, induced by phenylhydrazine, hemin and tetrachloromethane, and also during autoimmune hemolytic anemia. In the latter case a decrease in serum bilirubin content was observed, as well as a decrease in the amount of blood reticulocytes which reflects a milder course of the disease. The Sn complexes under study induce, in vivo, cytochrome P-450, inhibit microsomal heme oxygenase and decrease the intensity of lipid peroxidation. At the same time, in vitro the hepatic and splenic heme oxygenase activity is blocked only when a 0.1 μM concentration of Sn-TMe-3-PyP or Sn-protoporphyrin IX is added to the incubation mixture. Sn-TPP does not affect the activity of this enzyme in vitro.

    Most comprehensive & up-to-date research on PORPHYRINS
    Handbook of Porphyrin Science now available in 46 volumes